Lupus Anticoagulant Test: What to Know

Understanding the Lupus Anticoagulant (LA) Test

When I first see a patient with an unexplained deep vein thrombosis, a stroke at a young age, or recurrent miscarriages, one of the first tests I order is the lupus anticoagulant (LA) panel. This blood test looks for antibodies that interfere with normal blood clotting – ironically, they increase the risk of abnormal clots. Let me walk you through what this test involves, why it matters, and how to interpret the results.

What Is Lupus Anticoagulant?

Despite its name, lupus anticoagulant is not a treatment for lupus nor is it found exclusively in lupus patients. It is a type of antiphospholipid antibody – an autoantibody that targets phospholipid-binding proteins involved in coagulation. In the laboratory, these antibodies prolong clotting time tests (such as aPTT), giving the false impression of a bleeding tendency. In reality, LA promotes clot formation in arteries and veins, a condition known as antiphospholipid syndrome (APS).

Why Is This Test Ordered?

Your doctor may recommend a lupus anticoagulant test if you have:

• An unexplained blood clot (deep vein thrombosis, pulmonary embolism)
• Recurrent miscarriages (especially after 10 weeks of gestation)
• Stroke or transient ischemic attack in a young adult without other risk factors
• Unexplained prolonged aPTT on routine coagulation screening
• Known or suspected autoimmune diseases like systemic lupus erythematosus (SLE)

The test is also used to monitor patients with antiphospholipid syndrome and to guide treatment decisions.

How Is the Lupus Anticoagulant Test Performed?

The test requires a standard blood draw from a vein, usually in your arm. No fasting is necessary, but it is important to inform your doctor about all medications, especially anticoagulants like warfarin, heparin, or direct oral anticoagulants, as they can interfere with the test results. The laboratory uses a series of coagulation assays:

• Dilute Russell's Viper Venom Time (dRVVT) – the most specific test for LA
• Silica Clotting Time (SCT) – another sensitive test
• Hexagonal phase phospholipid neutralisation – confirmatory step

If the initial screening test is prolonged and the confirmatory test shows correction with excess phospholipid, the result is considered positive for lupus anticoagulant.

Reference Ranges for Lupus Anticoagulant

Lupus anticoagulant results are reported as either negative (normal) or positive. Some laboratories provide a ratio (e.g., dRVVT ratio). The table below shows typical reference ranges. Note: Reference ranges may vary slightly between laboratories.

It is important to note that transient positivity can occur with infections or certain medications. Therefore, a positive result is usually confirmed with repeat testing after 12 weeks.

What Do Abnormal Results Mean?

Positive Lupus Anticoagulant

A positive result indicates the presence of lupus anticoagulant antibodies in your blood. This does not mean you have lupus (SLE). Many people with positive LA have no symptoms, but in others it significantly increases the risk of:

• Venous thromboembolism (DVT, PE)
• Arterial thrombosis (stroke, heart attack)
• Pregnancy complications (miscarriage, pre-eclampsia, stillbirth)
• Thrombocytopenia (low platelet count)

If you have a positive result along with a prior clot or pregnancy loss, you likely meet the criteria for antiphospholipid syndrome (APS) and will require long-term anticoagulation therapy.

Negative Lupus Anticoagulant

A negative result is reassuring – it means no lupus anticoagulant antibodies were detected. However, if clinical suspicion remains high (e.g., recurrent clots with other positive antiphospholipid antibodies like anticardiolipin or anti-β2 glycoprotein I), further testing may be needed.

Is a Positive Lupus Anticoagulant Dangerous?

In my clinical practice, I reassure patients that a positive test alone is not a disease. The danger lies in the tendency to form clots. Without any prior thrombosis or pregnancy loss, the risk of a first clot is relatively low (about 1–2% per year). However, once you have had a clot, the recurrence risk is high without treatment. That is why we take a positive LA very seriously in the context of symptoms.

Lupus Anticoagulant During Pregnancy

Pregnant women with positive lupus anticoagulant face increased risks: miscarriage (especially after 10 weeks), intrauterine growth restriction, and pre-eclampsia. Treatment with low-molecular-weight heparin and low-dose aspirin dramatically improves pregnancy outcomes. I always recommend that women with known LA consult a high-risk obstetrician before conceiving.

How Is Lupus Anticoagulant Treated?

If you have APS (positive LA plus a thrombotic event), lifelong anticoagulation with warfarin (target INR 2.0–3.0) is standard. For those with recurrent clots despite warfarin, a higher INR target (3.0–4.0) or alternative agents may be used. In pregnancy, heparin-based therapy is preferred. Lifestyle measures – staying active, avoiding smoking, and managing other cardiovascular risk factors – also help reduce clot risk.

Lupus Anticoagulant vs. Anticardiolipin Antibodies

Both are part of the antiphospholipid antibody family. Lupus anticoagulant is detected by functional clotting assays, while anticardiolipin antibodies are measured by immunoassays. Having one or both increases the risk of APS. The lupus anticoagulant test is actually more strongly associated with thrombosis than anticardiolipin antibodies.

What to Do If Your Test Is Positive

First, don’t panic. Confirmatory testing after 12 weeks is essential. Discuss the results with a haematologist or rheumatologist. They will evaluate your complete history and decide if you need preventive anticoagulation. Many people with LA live full, active lives with proper monitoring and treatment.

LOINC codes: Lupus anticoagulant (LA) panel – 50556-9 (dRVVT screen), 50557-7 (dRVVT confirm).